Logo1
AASLD - The Liver Meeting 2011
Mr pencil

How would you like your name to appear on your certificate?



What activities did you attend at the event?
Agreement
By completing this form, you attest that you have participated in all selected activities in thier entirety.
Please rate the following:
The program was relevant to my work.
Usefulness of handouts/AV.
Quality of facilities.
How well did the educational sessions give a balanced view of therapeutic options, including the use of generic names?
If you rated any of the above questions with 'fair,' 'poor,' 'disagree,' or 'strongly disagree' please explain in detail (e.g. session title, speaker name, situation):
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
Please rate the speaker(s) as a group.  You will have the opportunity to elaborate on an individual speaker in the following question. 
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
If you have additional comments regarding the session or individual speaker(s) - e.g. teaching ability, expertise, organization of materials, etc. - please use the space below:
Having completed the activity, please rate your ability to meet each of the following objectives:
Compare the pros and cons on the use of different maintenance and induction agents
Discuss the utility of therapeutic drug monitoring and interactions and the potential for tailored dosing based on genotypic/phenotypic patterns
Describe immunosuppression management strategies in special populations (pediatrics, infectious diseases, cancer) and disease states (rejection, autoimmune disease, kidney injury, HCV)
Discuss HCV concerns in the era of triple therapy
Describe co-morbid conditions that need consideration in the post-transplant patient
Identify hepatitis B lab interpretation and mutations
Describe the natural history of cirrhosis
Distinguish a compensated from a decompensated patient
Identify the main complications that define decompensation
Contrast current and future approaches to minimize the impact of long term immunosuppression
Identify risk strata for patients presenting with each of the complications of cirrhosis
Explain how to manage patients according to each risk strata
Discuss complex hepatology case management
Evaluate hepatology concerns during pregnancy
Please answer the following:
Do you believe this activity was appropriate for the scope of your professional activities?
Was the educational content scientifically sound?

If faculty spoke about off-label or investigational uses of a product, was that information disclosed to you?

Was the mode of education effective to learning?
If you answered "No" to any of the above questions, please explain.
Did you perceive any product/service/company/commercial bias in any educational session you attended or materials you received?
If you answered "Yes" to the above question, please detail the situation below (e.g. session title, speaker name):
Were you solicited by sales personnel in an educational room (other areas do not matter) while you attended this educational activity?
If you answered "Yes" to the above question, please explain in detail (e.g. who, when, where):
What specifically did you learn during this activity that you intend to integrate into your practice?

What questions have arisen in your practice for which you need answers/strategies that you can implement?

What patient/client problems or patient/client challenges do you feel you are not able to address appropriately or to your satisfaction?
What problems are your patients/clients communicating to you that need attention or follow up?

Are you interested in basic, intermediate or advanced level trainings?

What barriers might you have that would interfere with implementation of new information learned from this training?

How can this training (collectively, the four courses for which nurse credit was available) be improved to better impact competence, performance and/or patient outcomes?

Additional comments:

Mr question